Tegoprubart is an investigational anti-CD40L monoclonal antibody that functions by potently inhibiting the CD40-CD40L costimulatory signaling pathway, thereby resulting in a reduction of both cellular and humoral immune responses, as well as the promotion of immunological tolerance, with preclinical data demonstrating significant efficacy in transplant models.
Reinheit:
98.10%
CAS Nummer:
[2628092-47-5]
Target-Kategorie:
Immunology/Inflammation related|||TNF
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
